You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 89 results:

Filters: Author is Katz, Ronit [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, et al. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Clin J Am Soc Nephrol. 2017 ;12(9):1386-1398.

D

Beasley JM, Katz R, Shlipak M, Rifkin DE, Siscovick D, Kaplan R. Dietary protein intake and change in estimated GFR in the Cardiovascular Health Study. Nutrition. 2014 ;30(7-8):794-9.

Deo R, Norby FL, Katz R, Sotoodehnia N, Adabag S, deFilippi CR, Kestenbaum B, Chen LY, Heckbert SR, Folsom AR, et al. Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population. Circulation. 2016 ;134(11):806-16.

Bansal N, Katz R, de Boer IH, Peralta CA, Fried LF, Siscovick DS, Rifkin DE, Hirsch C, Cummings SR, Harris TB, et al. Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol. 2015 ;10(3):363-71.

Jensen MK, Jensen RA, Mukamal KJ, Guo X, Yao J, Sun Q, Cornelis M, Liu Y, Chen M-H, Kizer JR, et al. Detection of genetic loci associated with plasma fetuin-A: A meta-analysis of genome-wide association studies from the CHARGE Consortium. Hum Mol Genet. 2017 .

C

Shlipak MG, Katz R, Fried LF, Jenny NSwords, Stehman-Breen CO, Newman AB, Siscovick D, Psaty BM, Sarnak MJ. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005 ;45(2):268-71.

Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005 ;118(12):1416.

Shlipak MG, Matsushita K, Arnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013 ;369(10):932-43.

Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, de Boer I, Palmas W, Siscovick D, Levey AS, Shlipak MG. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011 ;22(1):147-55.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NSwords, Psaty BM, Newman AB, Siscovick D, Shlipak MG. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005 ;142(7):497-505.

Moran A, Katz R, Smith NL, Fried LF, Sarnak MJ, Seliger SL, Psaty B, Siscovick DS, Gottdiener JS, Shlipak MG. Cystatin C concentration as a predictor of systolic and diastolic heart failure. J Card Fail. 2008 ;14(1):19-26.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005 ;352(20):2049-60.

Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes. 2010 ;3(2):159-64.

Seliger SL, Longstreth WT, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005 ;16(12):3721-7.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006 ;145(4):237-46.

O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, Siscovick DS, Shlipak MG. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study. Arch Intern Med. 2005 ;165(22):2666-70.

Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, Rifkin D, Tracy R, Newman AB, Shlipak MG. Cystatin C and aging success. Arch Intern Med. 2008 ;168(2):147-53.

de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, Rifkin DE, Sarnak MJ, Shlipak MG, Siscovick DS. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009 ;32(10):1833-8.

Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, Otto CM, Griffin BP. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol. 2007 ;50(20):1992-8.

Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009 ;204(1):298-303.

Shastri S, Tighiouart H, Katz R, Rifkin DE, Fried LF, Shlipak MG, Newman AB, Sarnak MJ. Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol. 2011 ;6(6):1410-7.

Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011 ;26(4):379-85.

Fried LF, Katz R, Cushman M, Sarnak M, Shlipak MG, Kuller L, Newman AB. Change in cardiovascular risk factors with progression of kidney disease. Am J Nephrol. 2009 ;29(4):334-41.

Mittalhenkle A, Stehman-Breen CO, Shlipak MG, Fried LF, Katz R, Young BA, Seliger S, Gillen D, Newman AB, Psaty BM, et al. Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study. Clin J Am Soc Nephrol. 2008 ;3(2):450-6.

B

Rifkin DE, Katz R, Chonchol M, Shlipak MG, Sarnak MJ, Fried LF, Newman AB, Siscovick DS, Peralta CA. Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study. Am J Hypertens. 2013 ;26(8):1037-44.

Pages